Why Hashimoto’s Causes Anxiety and Depression (and what to do about it)

If you’ve been told your thyroid labs look “normal” but you still feel anxious, depressed, foggy, and not like yourself — you are not crazy. There is a real, physiological reason this is happening, and it goes far beyond your thyroid numbers. Let me walk you through what’s actually going on in your body when you have Hashimoto’s and why your mental health can be so deeply affected.

What is Hashimoto’s thyroiditis?

Hashimoto’s thyroiditis is an autoimmune condition in which the immune system launches an ongoing attack against the thyroid gland. Clinically, this can present as visible thyroid swelling — if you tilt your head back, there may be a characteristic widened, raised area across the midline of the neck. In the lab test results, we’re looking for elevated thyroglobulin antibodies (TgAb) and thyroid peroxidase antibodies (TPO-Ab) as the defining markers.

Over time, this immune assault damages thyroid tissue and progressively reduces its function, leading to hypothyroidism. Importantly, 85–90% of people with hypothyroidism actually have Hashimoto’s as the underlying cause — which means most patients walking in with a low thyroid diagnosis have an autoimmune condition that hasn’t been properly identified or addressed.¹

This isn’t just a thyroid problem — it’s a whole-body inflammation problem

Here’s what most patients are never told: Hashimoto’s is not just localized inflammation in the thyroid. It produces systemic inflammation that travels throughout the body — into your joints, your muscles, and critically, into your brain.

This is why, even when thyroid hormone replacement (Synthroid, Armor, Nature-Throid, compounded T3/T4) brings your TSH, free T3, and free T4 into a normal range, many patients still feel terrible. The thyroid numbers may look fine, but the underlying immune dysregulation and neuroinflammation are still actively at play.

Research consistently demonstrates elevated pro-inflammatory cytokines — including IL-1β, IL-6, and TNF-α — in patients with Hashimoto’s, independent of thyroid hormone status.² This systemic inflammatory burden is what drives the fatigue, joint achiness, fibromyalgia-like muscle pain, and mood disturbances so common in those with this autoimmune disease.

How Hashimoto’s directly inflames the brain

Neuroinflammation and Glial Priming

The brain is not exempt from the inflammatory cascade of Hashimoto’s. Two key structures are involved:

Neurons — the cells that transmit information throughout the brain — require a clear, low-inflammation environment to fire efficiently. When systemic inflammation from Hashimoto’s crosses into the central nervous system, it slows neuronal transmission, contributing to the classic symptoms of brain fog, word-finding difficulty, mental sluggishness, and slowed processing.

Glia — the structural and support scaffolding of the brain — become activated and inflamed in a process called glial priming. Primed microglia (the brain’s resident immune cells) enter a state of hyperreactivity, releasing additional pro-inflammatory mediators and amplifying neuroinflammation.³ This is the same mechanism seen after traumatic brain injury and concussion. The result: persistent brain fog, cognitive slowing, low mood, emotional flatness, and depression.

TPO Antibodies and the Cerebellum

Here is one of the most clinically significant — and most overlooked — mechanisms connecting Hashimoto’s to anxiety and neurological symptoms: thyroid peroxidase antibodies can cross the blood-brain barrier and bind to the midline cerebellum.

As the immune system attacks the thyroid and releases TPO, circulating TPO antibodies have been found to attach to cerebellar tissue. The cerebellum is the brain’s master coordinator of balance, spatial orientation, coordination, and — through its connections to the limbic system — emotional regulation and anxiety modulation.⁴⁵

When TPO antibodies bind here, patients experience:

• Dizziness or vertigo
• Feeling “spinny” or off-balance
• Sensitivity to busy visual environments or crowds
• Motion sickness that wasn’t there before (e.g., riding in the back seat, unable to tolerate carnival rides)
• Coordination issues
• A persistent, underlying anxiety that feels distinctly physical

This is known in the literature as Hashimoto’s Encephalopathy in its more severe presentations, but subclinical cerebellar involvement from TPO antibodies is far more common than most clinicians recognize.⁶ It explains why so many Hashimoto’s patients describe their anxiety as having a physical, “spinning” quality that doesn’t respond well to standard anxiolytics or antidepressants alone.

Why women are disproportionately affected

Approximately 80% of autoimmune conditions occur in women, and Hashimoto’s follows this pattern strongly.⁷ This is not coincidental — it is rooted in the powerful immune-modulating role that estrogen plays throughout the body. When estrogen is abundant and balanced, it functions as a key regulator of immune tolerance. When it drops — whether suddenly or gradually — the immune system can become dysregulated in ways that open the door to autoimmunity.

Estrogen exerts its protective effects through several interconnected mechanisms. It supports the integrity of the gut lining, helping to prevent intestinal permeability. It promotes a balanced Th1/Th2/Th17 immune response by upregulating regulatory T cells (Tregs) — the immune system’s “brakes.”⁸ Estrogen also directly modulates B cell activity and reduces the production of pro-inflammatory cytokines including IL-6, IL-17, and TNF-α.⁹ When estrogen levels fall, Treg activity declines, inflammatory cytokine production rises, and the gut barrier becomes more permeable — a perfect storm for autoimmune activation.

This is why Hashimoto’s so commonly emerges or flares at predictable hormonal transition points:

Postpartum

During pregnancy, estrogen and progesterone are at peak levels and the immune system shifts into a more tolerant, anti-inflammatory state. After delivery, estrogen drops precipitously — sometimes within 24–48 hours. This sudden withdrawal can trigger an immune rebound, and in genetically susceptible women, this can initiate or accelerate thyroid autoimmunity. Postpartum thyroiditis affects an estimated 5–10% of women in the first year after delivery.¹⁰

Perimenopause

The years leading up to menopause are characterized by erratic, declining estrogen with unpredictable surges and crashes. Progesterone, which also has anti-inflammatory and immune-tolerizing properties, declines even earlier — often leaving women in a state of relative estrogen dominance followed eventually by estrogen deficiency, both of which can dysregulate immune function in different ways.¹¹ Many women first develop Hashimoto’s or see a dramatic worsening of their antibody levels during perimenopause.

Menopause

The sustained low-estrogen environment of menopause removes the ongoing anti-inflammatory signaling estrogen provided. Without it, the gut lining becomes more vulnerable to permeability, microbial translocation increases low-grade immune activation, and the threshold for autoimmune flare lowers significantly. Research confirms that estrogen deficiency is associated with increased intestinal permeability and elevated markers of systemic inflammation.¹²

Surgical menopause

Women who undergo oophorectomy (removal of the ovaries) experience an abrupt, complete loss of ovarian estrogen that is even more physiologically jarring than natural menopause. Thyroid autoimmunity can emerge or accelerate rapidly in its wake.

If you developed Hashimoto’s — or noticed your symptoms significantly worsen — after having a baby, entering perimenopause, reaching menopause, or undergoing gynecologic surgery, estrogen’s role in your immune dysregulation is not a side story. It is central to your case. A thorough evaluation of sex hormone status, including estradiol, progesterone, and DHEA-S, belongs in every Hashimoto’s workup.

The root triggers: what actually started this?

Thyroid hormone replacement treats low thyroid output but doesn’t address what triggered the immune system to attack the thyroid in the first place. A thorough functional medicine approach investigates:

1. Genetic Predisposition

There is always a genetic component. HLA-DQ2 and HLA-DQ8 variants are particularly significant — these are the same SNPs that confer susceptibility to celiac disease, and they set up a shared immune vulnerability between gluten exposure and thyroid tissue.¹³ Having a mother, grandmother, or aunt with hypothyroidism, Hashimoto’s, or another autoimmune condition is clinically meaningful information.

2. Gluten

Gluten is the most important dietary trigger to address in Hashimoto’s — it is a phenomenon of molecular mimicry and cross-reactivity. The protein structure of gliadin is structurally similar to thyroid tissue proteins. When the immune system mounts an antibody response to gluten, those same antibodies can attack the thyroid gland.¹⁴¹⁵

The top five dietary cross-reactors to evaluate are: gluten, dairy, corn, soy, and eggs — with gluten as the primary driver. Nightshades and lectins may also be relevant in some individuals.

3. Intestinal Permeability (Leaky Gut)

Increased gut permeability — where tight junctions of the intestinal lining break down and allow undigested food particles and bacterial antigens (like LPS) into systemic circulation — is a critical driver of autoimmune activation.¹⁶ When the gut is “leaky,” the immune system is in a constant state of alarm. Healing the gut is not optional in Hashimoto’s management — it is foundational.

4. Viral and Bacterial Triggers

Several pathogens have documented associations with Hashimoto’s onset:

• Epstein-Barr Virus (EBV): EBV reactivation is a well-established trigger for thyroid autoimmunity¹⁷
• H. pylori: Gastric H. pylori infection is a significant upstream trigger — if you have a history of ulcers, epigastric burning, or gastric symptoms, testing for H. pylori is warranted¹⁸
• COVID-19: Post-COVID thyroiditis and new-onset Hashimoto’s have been reported with increasing frequency¹⁹

5. Hormonal Shifts and Estrogen Loss

As detailed above, the loss of estrogen removes one of the body’s most important natural immune regulators. The result is increased intestinal permeability, reduced Treg activity, elevated inflammatory cytokines, and a lowered threshold for autoimmune activation. Hormonal status must be evaluated and addressed as part of any complete Hashimoto’s protocol.

6. Chronic Stress and HPA Axis Dysregulation

Chronic psychological or physiological stress drives cortisol dysregulation, which in turn directly increases intestinal permeability and suppresses regulatory immune function. High cortisol is a leaky gut trigger — and a leaky gut is an autoimmune trigger. The HPA-gut-immune axis is a central feedback loop in Hashimoto’s pathophysiology.²⁰ Chronic stress is not just a lifestyle factor; it is a measurable physiological driver of autoimmune progression.

7. Chemical and Heavy Metal Exposures

Environmental toxicants — pesticides, heavy metals, mold mycotoxins, plasticizers, and other endocrine-disrupting chemicals — can directly trigger or perpetuate immune dysregulation. Auditing your daily chemical burden through household products, food quality, and environmental exposures is a meaningful clinical intervention.

What you can do about it

Monitor the right labs every six months

• TSH, Free T3, Free T4 — thyroid hormone status
• Thyroid Peroxidase Antibodies (TPO-Ab) — your inflammatory activity marker; we want this trending down
• Thyroglobulin Antibodies (TgAb) — once positive, will likely remain positive; the number itself is less clinically meaningful than TPO trends
• Estradiol, Progesterone, DHEA-S — hormonal status directly impacts immune regulation and should be part of your ongoing picture

Note: TgAb positivity simply confirms the presence of thyroid autoimmunity. TPO-Ab levels are the more actionable marker — they reflect the degree of active destruction occurring, and how much circulating TPO is available to trigger cerebellar and systemic inflammatory effects.

Targeted Supplementation

• Selenium — 200 mcg/day: Selenium is the most well-studied nutrient intervention for Hashimoto’s. Multiple randomized controlled trials demonstrate that selenium supplementation significantly reduces TPO antibody levels.²¹²² Lowering TPO is directly relevant to reducing cerebellar binding and the anxiety/dizziness complex described above.
• Black Seed Oil (Nigella sativa): Emerging research supports its use for lowering thyroid antibody levels and modulating autoimmune activity.²³
• Vitamin D: Vitamin D receptor signaling plays a central role in immune tolerance. Deficiency is strongly associated with autoimmune thyroid disease, and optimization is a foundational intervention.²⁴
• Glutathione: The master antioxidant and critical modulator of immune regulation and neuroinflammation. Supports both gut barrier integrity and brain inflammation reduction.
• Bioflavonoids for Neuroinflammation: Compounds including quercetin, luteolin, rutin, and apigenin have demonstrated meaningful anti-neuroinflammatory activity through microglial modulation.²⁵ These are particularly relevant for addressing the brain fog, glial priming, and mood disruption associated with Hashimoto’s.
• Additional anti-inflammatory support: Curcumin (turmeric) and resveratrol have demonstrated benefit in modulating inflammatory pathways relevant to autoimmune thyroid disease.

Blood Sugar Stability

Blood sugar dysregulation — both hyperglycemia and hypoglycemia — activates inflammatory pathways and drives immune dysregulation. Stabilizing blood sugar is not optional in autoimmune management; it is foundational.

Reduce Environmental Toxic Burden

Audit your household chemical exposures — cleaning products, personal care products, laundry detergents, and pesticide-laden foods. Tools like the Yuka app can help you quickly assess product safety. Every reduction in your total toxic burden reduces the immune system’s overall provocation load.

The Bottom Line

If you have Hashimoto’s and you’re struggling with anxiety, depression, brain fog, dizziness, or emotional dysregulation — these are not separate problems from your thyroid condition. They are direct, mechanistic consequences of the neuroinflammation, glial priming, cerebellar TPO binding, and systemic inflammatory burden that come with Hashimoto’s. And for many women, declining estrogen is the match that lit the fire.

Thyroid hormone replacement is not enough on its own. The goal is to identify and remove your immune triggers, restore hormonal balance, calm systemic inflammation, heal the gut, and support the brain. Only then do patients truly start to feel like themselves again.

References

1. Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4-5):391-397.
2. Figura N, et al. Cytokine levels in Hashimoto’s thyroiditis and their relationship with clinical and laboratory features. Clin Immunol. 2020.
3. Bhatt DL, et al. Neuroinflammation and microglial priming in systemic autoimmune disease. J Neuroinflammation. 2019.
4. Ferracci F, Bertiato G, Moretto G. Hashimoto’s encephalopathy: epidemiologic data and pathogenetic considerations. J Neurol Sci. 2004;217(2):165-168.
5. Dalmau J, Rosenfeld MR. Autoimmune encephalitis update. Neuro-Oncology. 2014.
6. Castillo P, et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol. 2006;63(2):197-202.
7. Fairweather D, Rose NR. Women and autoimmune diseases. Emerg Infect Dis. 2004;10(11):2005-2011.
8. Straub RH. The complex role of estrogens in inflammation. Endocr Rev. 2007;28(5):521-574.
9. Cutolo M, et al. Sex hormones and autoimmune rheumatic diseases. Ann N Y Acad Sci. 2006;1069:399-409.
10. Stagnaro-Green A. Postpartum thyroiditis. J Clin Endocrinol Metab. 2002;87(9):4042-4047.
11. Pearce EN. Thyroid dysfunction in perimenopausal and postmenopausal women. Menopause Int. 2007;13(1):8-13.
12. Gupta A, et al. Estrogen receptor-mediated regulation of intestinal epithelial barrier function. Mol Cell Endocrinol. 2022;544:111566.
13. Ban Y, Tomer Y. Genetic susceptibility in thyroid autoimmunity. Pediatr Endocrinol Rev. 2005;3(1):20-32.
14. Sategna-Guidetti C, et al. Autoimmune thyroid diseases and celiac disease. Eur J Gastroenterol Hepatol. 2001;13(2):199-204.
15. Ventura A, et al. Gluten-dependent diabetes-related and thyroid-related autoantibodies in patients with celiac disease. J Pediatr. 2000;137(2):263-265.
16. Mu Q, Kirby J, Reilly CM, Luo XM. Leaky gut as a danger signal for autoimmune diseases. Front Immunol. 2017;8:598.
17. Mori K, et al. Does the Epstein-Barr virus infection play a role in Hashimoto’s thyroiditis? Endocr J. 1998;45(4):519-524.
18. Figura N, et al. The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders. J Physiol Pharmacol. 1999;50(5):817-826.
19. Ruggeri RM, et al. Autoimmune thyroid diseases and COVID-19. J Clin Endocrinol Metab. 2021;106(10):e4036-e4045.
20. Straub RH, Cutolo M. Glucocorticoids and chronic inflammation. Rheumatology. 2016;55(suppl 2):ii6-ii14.
21. Gärtner R, et al. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab. 2002;87(4):1687-1691.
22. Toulis KA, et al. Selenium supplementation in the treatment of Hashimoto’s thyroiditis: a systematic review and meta-analysis. Thyroid. 2010;20(10):1163-1173.
23. Datau EA, et al. Efficacy of Nigella sativa on serum free testosterone and metabolic disturbances in central obese male. Acta Med Indones. 2010;42(3):130-134.
24. Unal AD, et al. Vitamin D deficiency is related to thyroid antibodies in autoimmune thyroiditis. Cent Eur J Immunol. 2014;39(4):493-497.
25. Jang S, et al. Luteolin inhibits microglia and alters hippocampal-dependent spatial working memory in aged mice. J Nutr. 2010;140(10):1892-1898.